Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Enterprise Value (2016 - 2025)

Collegium Pharmaceutical (COLL) has 10 years of Enterprise Value data on record, last reported at -$285.9 million in Q3 2025.

  • For Q3 2025, Enterprise Value fell 138.3% year-over-year to -$285.9 million; the TTM value through Sep 2025 reached -$285.9 million, down 138.3%, while the annual FY2024 figure was -$95.6 million, 69.23% up from the prior year.
  • Enterprise Value reached -$285.9 million in Q3 2025 per COLL's latest filing, down from -$137.2 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$95.6 million in Q4 2024 and bottomed at -$325.5 million in Q2 2023.
  • Average Enterprise Value over 5 years is -$203.0 million, with a median of -$186.4 million recorded in 2021.
  • Peak YoY movement for Enterprise Value: plummeted 165.21% in 2023, then skyrocketed 69.23% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$186.4 million in 2021, then grew by 6.83% to -$173.7 million in 2022, then plummeted by 78.8% to -$310.5 million in 2023, then surged by 69.23% to -$95.6 million in 2024, then crashed by 199.13% to -$285.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$285.9 million in Q3 2025, -$137.2 million in Q2 2025, and -$116.0 million in Q1 2025.